Overview

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
A single-center, single-arm, open-label, multi-dose, three-period study was conducted in healthy Chinese volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Hydrochlorothiazide